| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/24/2005 | US20050065208 Benzofuranes and their use in the treatment of atrial fibrillation |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/24/2005 | US20050065170 Compounds |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/24/2005 | US20050065157 Carbazole derivatives and their use as npy5 receptor antagonists |
| 03/24/2005 | US20050065140 Antidepressant; side effect reduction |
| 03/24/2005 | US20050065121 Using probucol ester |
| 03/24/2005 | US20050065118 Compound containing 1,3,4-thiadiazole group; anticancer agents; autoimmune disease; antidiabetic agents |
| 03/24/2005 | US20050065116 Thiazolopyrimidines useful as TNFalpha inhibitors |
| 03/24/2005 | US20050065110 Synergistic mixture; antioxidant; cardiovascular disorders; antidiabetic agents |
| 03/24/2005 | US20050065102 Medicinal compositions |
| 03/24/2005 | US20050065097 Liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 03/24/2005 | US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/24/2005 | US20050065085 Tissue disorders in response to injuries with administering polypeptidesand antibodies with gene delivery for inflammation such as arthritis |
| 03/24/2005 | US20050065079 Therapy for metabolism disorders ; obesity; antilipemic agents; atherosclerosis; hypotensive agents; antidiabetic agents |
| 03/24/2005 | US20050064586 Somatic cell derived embryonic stem cells and its differentiated cells |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064539 Glycoprotein and process for producing the same |
| 03/24/2005 | US20050064534 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 03/24/2005 | US20050064493 Antibodies specific for vascular endothelial growth factor-B and DNA coding therefor |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050064416 Methods for diagnosing and treating heart disease |
| 03/24/2005 | US20050064404 Regulation of human serotonin-like g protein-coupled receptor |
| 03/24/2005 | US20050064048 Compositions comprising organic extracts of geum japonicum thunb var. and the use thereof |
| 03/24/2005 | US20050063991 administrating. to a diabetic or arteriosclerosis patient an effective amount of crude Dunaliella powder containing an approximately 1:1 ratio of all-trans and 9-cis beta -carotene |
| 03/24/2005 | US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody |
| 03/24/2005 | US20050063969 Assay |
| 03/24/2005 | US20050063961 Hematopoietic stem cells and endothelial progenitor cells; express the cell surface antigen CD31; delivering transgenes to the eye for cell-based gene therapy; treating ocular diseases such as retinopathy |
| 03/24/2005 | US20050063943 Conjugated of hydroxyalkyl starch and an active agent |
| 03/24/2005 | DE10341233A1 Composition, useful to treat e.g. atrial fibrillation, atrial flutter and atrial arrhythmia, comprises at least one beta-blocker and at least one compound of a phenylcarboxylic acid amide derivative |
| 03/24/2005 | CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
| 03/24/2005 | CA2539454A1 Preventive for cerebral stroke recurrence |
| 03/24/2005 | CA2538425A1 Crystals of a heterocyclic compound |
| 03/24/2005 | CA2538075A1 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
| 03/24/2005 | CA2538009A1 Combination of phenylcarboxamides with beta-adrenergic receptor blockers and use thereof for the treatment of atrial arrhythmias |
| 03/24/2005 | CA2537482A1 Use of adipose tissue cells for initiating the formation of a functional vascular network |
| 03/23/2005 | EP1516877A1 Amine derivatives as protease inhibitors |
| 03/23/2005 | EP1516866A1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
| 03/23/2005 | EP1516639A1 Device in the treatment of pulmonary vasoconstriction and asthma |
| 03/23/2005 | EP1516622A1 Stable diltiazem hydrochloride pharmaceutical composition for cutaneous application and process for the preparation thereof |
| 03/23/2005 | EP1516620A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 03/23/2005 | EP1516617A2 Use of a thiazolidinedione for reducing apoptosis of pancreatic beta cells |
| 03/23/2005 | EP1516597A1 Drug eluting stent |
| 03/23/2005 | EP1516190A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor |
| 03/23/2005 | EP1516064A2 Methods of using 46828, a human acyl-coa synthetase |
| 03/23/2005 | EP1516061A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor |
| 03/23/2005 | EP1515984A1 Peptide derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 03/23/2005 | EP1515978A1 Sulfur-containing phospholipid derivatives |
| 03/23/2005 | EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/23/2005 | EP1515968A2 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 03/23/2005 | EP1515965A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors |
| 03/23/2005 | EP1515961A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 03/23/2005 | EP1515955A2 Chemical process |
| 03/23/2005 | EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 03/23/2005 | EP1515949A1 Mitotic kinesin inhibitors |
| 03/23/2005 | EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 03/23/2005 | EP1515942A1 Carboxamides derivatives |
| 03/23/2005 | EP1515941A1 2-naphthamide derivatives |
| 03/23/2005 | EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 03/23/2005 | EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 03/23/2005 | EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 03/23/2005 | EP1515732A1 Cerebral protection with a gas comprising xenon |
| 03/23/2005 | EP1515731A1 Anti-spasmodic comprising xenon |
| 03/23/2005 | EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 03/23/2005 | EP1515722A2 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1515721A1 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1515720A1 Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions |
| 03/23/2005 | EP1515718A2 Modulation of activation of glucocorticoid receptors by breakdown products of glucocorticoids |
| 03/23/2005 | EP1515717A1 Calcium salts of indole derived statins |
| 03/23/2005 | EP1515716A2 Indole derivatives having anti-angiogenetic activity |
| 03/23/2005 | EP1515707A2 Method of treating atherosclerosis and other inflammatory diseases |
| 03/23/2005 | EP1515704A1 Microcapsules for the delayed, controlled release of perindopril |
| 03/23/2005 | EP1421182A4 Methods of inducing differentiation of stem cells |
| 03/23/2005 | EP1328268B1 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 03/23/2005 | EP1152764A4 Compositions and methods for use in targeting vascular destruction |
| 03/23/2005 | EP1100469B1 Rapidly disintegrable solid preparation |
| 03/23/2005 | EP1089733B1 Use of optically pure (+)-norcisapride for treating irritable bowel syndrome |
| 03/23/2005 | EP1045832B1 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof |
| 03/23/2005 | CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist |
| 03/23/2005 | CN1599737A Ring fused pyrazole derivatives |
| 03/23/2005 | CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists |
| 03/23/2005 | CN1599731A Benzothiazepine derivatives |
| 03/23/2005 | CN1599730A Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 03/23/2005 | CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 03/23/2005 | CN1599717A Cyclic diamine compounds having fused-ring groups |
| 03/23/2005 | CN1599622A Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease |
| 03/23/2005 | CN1599621A Use of collagenase to facilitate guide wire crossing in total arterial occlusions |
| 03/23/2005 | CN1599620A Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 03/23/2005 | CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/23/2005 | CN1599608A Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 03/23/2005 | CN1599607A Carbinols for the treatment of neuropathic dysfunction |
| 03/23/2005 | CN1599604A Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 03/23/2005 | CN1599602A Peroxisome proliferator activated receptor ligands and process for producing the same |
| 03/23/2005 | CN1597678A Extraction method of hawthorn leaf total flarone |
| 03/23/2005 | CN1597676A Jujube kernel saponin derivative and its preparation method and use |
| 03/23/2005 | CN1597667A Quinazoline derivatives as angiogenesis inhibitors |
| 03/23/2005 | CN1596983A Composition of nanometer SOD and ginseng or its extract and its preparation method |
| 03/23/2005 | CN1596979A Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 03/23/2005 | CN1596962A Capsule for treating hemorrhoid inflammation and its preparation method |
| 03/23/2005 | CN1596960A Traditional Chinese medicine for treating brain arteria induration |